|
Cambridge Nutritional Sciences PLC on Tuesday said it expects to post pretax profit of £1.6 million for the year ended March 31, swinging from a £750,000 loss the year prior, driven by a settlement windfall and improved margins. Shares in Cambridge Nutritional were up 7.6% at 3.07 pence each on Tuesday afternoon in London. The London-based medical diagnostics firm offering health and nutrition products said total income for the year will be around £11.1 million, up 12% from £9.9 million in financial 2024. This includes £2.5 million of exceptional income from a UK Department of Health & Social Care settlement. Excluding exceptional items and other income, revenue is expected to be £8.3 million, down 15% from the prior year’s £9.8 million. However, adjusted earnings before interest, tax, depreciation and amortisation are expected to come in at £400,000, up from £200,000 and in line with market expectations. Gross profit margin improved to 65% from 62%, supported by continued investment in production, improved yields, and tighter cost control, Cambridge Nutritional said. Net cash at year-end was £4.9 million, down slightly from £5.4 million a year ago. Chief Executive Officer James Cooper said the 2025 result reflects ‘solid profit even before we see the benefit of our new sales pipeline’, and noted early signs of growth in key international markets. ‘The new financial year has started positively,’ the company added, citing expanding distributor relationships in Europe, the US and India. It also flagged continued investment in leadership and infrastructure to support future growth. Cambridge Nutritional said a recent fine of £35,000 from Exeter Magistrates Court over historical health and safety breaches in 2018 will be treated as an exceptional item and will not impact key adjusted performance metrics. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
